BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9368869)

  • 1. Heterozygosity for Tay-Sachs and Sandhoff diseases among Massachusetts residents with French Canadian background.
    Prence EM; Jerome CA; Triggs-Raine BL; Natowicz MR
    J Med Screen; 1997; 4(3):133-6. PubMed ID: 9368869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterozygosity for Tay-Sachs and Sandhoff diseases in non-Jewish Americans with ancestry from Ireland, Great Britain, or Italy.
    Branda KJ; Tomczak J; Natowicz MR
    Genet Test; 2004; 8(2):174-80. PubMed ID: 15345116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the risk for Tay-Sachs disease in individuals of French Canadian ancestry living in new England.
    Martin DC; Mark BL; Triggs-Raine BL; Natowicz MR
    Clin Chem; 2007 Mar; 53(3):392-8. PubMed ID: 17259242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analyses of Tay-Sachs disease: studies on Tay-Sachs carriers of French Canadian background living in New England.
    Triggs-Raine B; Richard M; Wasel N; Prence EM; Natowicz MR
    Am J Hum Genet; 1995 Apr; 56(4):870-9. PubMed ID: 7717398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sandhoff disease heterozygote detection: a component of population screening for Tay-Sachs disease carriers. I. Statistical methods.
    Cantor RM; Lim JS; Roy C; Kaback MM
    Am J Hum Genet; 1985 Sep; 37(5):912-21. PubMed ID: 4050790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence and carrier frequency of Tay-Sachs disease in the French-Canadian population of Quebec based on retrospective data from 24 years, 1992-2015.
    Sillon G; Allard P; Drury S; Rivière JB; De Bie I
    J Genet Couns; 2020 Dec; 29(6):1173-1185. PubMed ID: 32302469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygosity for Tay-Sachs disease in non-Jewish Americans with ancestry from Ireland or Great Britain.
    van Bael M; Natowicz MR; Tomczak J; Grebner EE; Prence EM
    J Med Genet; 1996 Oct; 33(10):829-32. PubMed ID: 8933335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tay-Sachs disease in persons of French-Canadian heritage in northern New England.
    Palomaki GE; Williams J; Haddow JE; Natowicz MR
    Am J Med Genet; 1995 May; 56(4):409-12. PubMed ID: 7604851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of homozygotes and heterozygote carriers of GM2-gangliosidosis].
    Aronovich EL; Krasnopol'skaia KD; Kukharenko VI; Pichugina EM
    Genetika; 1986 Aug; 22(8):2179-85. PubMed ID: 3770476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reconstruction of hexosaminidase isoenzymes during hybridization of fibroblasts from Tay-Sachs and Sandhoff diseases].
    Beĭer EM; Vidershaĭn GIa; Venert M
    Biull Eksp Biol Med; 1984 Jan; 97(1):83-6. PubMed ID: 6229294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygote screening for Tay-Sachs disease: past successes and future challenges.
    Natowicz MR; Prence EM
    Curr Opin Pediatr; 1996 Dec; 8(6):625-9. PubMed ID: 9018448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sandhoff disease heterozygote detection: a component of population screening for Tay-Sachs disease carriers. II. Sandhoff disease gene frequencies in American Jewish and non-Jewish populations.
    Cantor RM; Roy C; Lim JS; Kaback MM
    Am J Hum Genet; 1987 Jul; 41(1):16-26. PubMed ID: 2955697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tay-Sachs disease--carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network.
    Kaback M; Lim-Steele J; Dabholkar D; Brown D; Levy N; Zeiger K
    JAMA; 1993 Nov; 270(19):2307-15. PubMed ID: 8230592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tay-Sachs disease carrier screening: a model for prevention of genetic disease.
    Kaplan F
    Genet Test; 1998; 2(4):271-92. PubMed ID: 10464605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tay-Sachs and Sandhoff diseases: enzymatic diagnosis in dried blood spots on filter paper: retrospective diagnoses in newborn-screening cards.
    Chamoles NA; Blanco M; Gaggioli D; Casentini C
    Clin Chim Acta; 2002 Apr; 318(1-2):133-7. PubMed ID: 11880123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intron 7 donor splice site transition: a second Tay-Sachs disease mutation in French Canada.
    Hechtman P; Boulay B; De Braekeleer M; Andermann E; Melançon S; Larochelle J; Prevost C; Kaplan F
    Hum Genet; 1992 Dec; 90(4):402-6. PubMed ID: 1483696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Segregation of Tay-Sachs and Sandhoff alleles in a non-Jewish family.
    Lane AB; Young E; Jenkins T
    Am J Hum Genet; 1980 Nov; 32(6):920-6. PubMed ID: 7446530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More than one mutant allele causes infantile Tay-Sachs disease in French-Canadians.
    Hechtman P; Kaplan F; Bayleran J; Boulay B; Andermann E; de Braekeleer M; Melançon S; Lambert M; Potier M; Gagné R
    Am J Hum Genet; 1990 Nov; 47(5):815-22. PubMed ID: 2220821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GM2 gangliosidoses in Spain: analysis of the HEXA and HEXB genes in 34 Tay-Sachs and 14 Sandhoff patients.
    Gort L; de Olano N; Macías-Vidal J; Coll MA;
    Gene; 2012 Sep; 506(1):25-30. PubMed ID: 22789865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common HEXB polymorphisms reduce serum HexA and HexB enzymatic activities, potentially masking Tay-Sachs disease carrier identification.
    Vallance H; Morris TJ; Coulter-Mackie M; Lim-Steele J; Kaback M
    Mol Genet Metab; 2006 Feb; 87(2):122-7. PubMed ID: 16352452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.